| Literature DB >> 23437386 |
Christian Brochu1, Miguel A Cabrita, Brian D Melanson, Jeffrey D Hamill, Rosanna Lau, M A Christine Pratt, Bruce C McKay.
Abstract
The cold inducible RNA binding protein (CIRBP) responds to a wide array of cellular stresses, including short wavelength ultraviolet light (UVC), at the transcriptional and post-translational level. CIRBP can bind the 3'untranslated region of specific transcripts to stabilize them and facilitate their transport to ribosomes for translation. Here we used RNA interference and oligonucleotide microarrays to identify potential downstream targets of CIRBP induced in response to UVC. Twenty eight transcripts were statistically increased in response to UVC and these exhibited a typical UVC response. Only 5 of the 28 UVC-induced transcripts exhibited a CIRBP-dependent pattern of expression. Surprisingly, 3 of the 5 transcripts (IL1B, IL8 and TNFAIP6) encoded proteins important in inflammation with IL-1β apparently contributing to IL8 and TNFAIP6 expression in an autocrine fashion. UVC-induced IL1B expression could be inhibited by pharmacological inhibition of NFκB suggesting that CIRBP was affecting NF-κB signaling as opposed to IL1B mRNA stability directly. Bacterial lipopolysaccharide (LPS) was used as an activator of NF-κB to further study the potential link between CIRBP and NFκB. Transfection of siRNAs against CIRBP reduced the extent of the LPS-induced phosphorylation of IκBα, NF-κB DNA binding activity and IL-1β expression. The present work firmly establishes a novel link between CIRBP and NF-κB signaling in response to agents with diverse modes of action. These results have potential implications for disease states associated with inflammation.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23437386 PMCID: PMC3578848 DOI: 10.1371/journal.pone.0057426
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Small inhibitory RNAs targeting CIRBP inhibit the basal and UVC-induced expression of the protein.
Fibroblasts were transfected with either control (NT) or CIRBP siRNAs. Seventy-two hours later, cells were exposed to 0 or 20 J/m2 of UVC. Whole cell lysates were collected 12 hours later for immunoblot analysis of CIRBP expression. Quantitation of this and similar immunoblots indicates that transfection of these cells with siRNA against CIRBP reduced CIRBP expression by over 80% compared to the unirradiated NT control sample (n = 5).
UVC-induced transcripts.
| Symbol | Gene ID | Expression | GO Annotation | p53 | |||||
| NT | CIRBP | Apop | Stress | -ve | |||||
| ATF3 | 467 | 5.4±1.0 | 42.2 | 6.6±0.4 | 97.0 | ○ | |||
| HSPB6 | 126393 | 5.1±1.6 | 34.3 | 2.7±2.5 | 6.5 | ○ | |||
|
| 7832 | 4.6±0.6 | 24.3 | 3.5±0.7 | 11.3 | ○–
| ○ | ○ | ○ |
| RRAD | 6234 | 4.3±1.1 | 19.7 | 5.1±0.9 | 34.3 | ○ | |||
| GDF15 | 9518 | 3.9±0.6 | 14.9 | 4.3±1.3 | 19.7 | ○ | |||
| COTL1 | 23406 | 3.9±1.3 | 14.9 | 3.4±0.1 | 10.6 | ||||
| MAP3K4 | 4216 | 3.6±0.1 | 12.1 | 3.2±0.4 | 9.2 | ○ | |||
|
| 3553 | 3.4±0.9 | 10.6 | 1.0±0.2 | 2.0 | ○ | ○ | ○ | |
| KBTBD8 | 84541 | 3.3±0.9 | 9.8 | 2.7±0.1 | 6.5 | ||||
| TP53INP1 | 94241 | 3.3±0.2 | 9.8 | 3.0±0.4 | 8.0 | ○ | ○ | ||
| SESN1 | 27244 | 3.2±0.6 | 9.2 | 2.3±0.1 | 4.9 | ○ | ○ | ○ | |
| GADD45A | 1647 | 3.1±0.6 | 8.6 | 3.0±0.1 | 8.0 | ○ | ○ | ○ | |
| SAT1 | 6303 | 3.1±0.2 | 8.6 | 3.0±0.2 | 8.0 | ||||
|
| 5366 | 3.1±0.1 | 8.6 | 3.2±0.1 | 9.2 | ○ | ○ | ||
| TNFRSF10D | 8793 | 3.0±0.6 | 8.0 | 2.4±0.8 | 5.3 | ○– | ○ | ||
| C10orf2 | 56652 | 3.0±0.4 | 8.0 | 2.2±0.1 | 4.6 | ||||
| CLP1 | 10978 | 3.0±0.4 | 8.0 | 2.7±0.1 | 6.5 | ||||
| BHLHB2 | 8553 | 2.8±1.2 | 7.0 | 2.6±0.2 | 6.1 | ||||
| HMOX1 | 3162 | 2.8±0.9 | 7.0 | 1.8±1.1 | 3.5 | ○– | ○ | ○ | |
| HIST2H2BE | 8349 | 2.7±0.5 | 6.5 | 2.3±0.1 | 4.9 | ||||
| TOB1 | 10140 | 2.7±0.4 | 6.5 | 2.4±0.2 | 5.3 | ○ | |||
|
| 7130 | 2.6±0.5 | 6.1 | 1.4±0.1 | 2.6 | ○ | |||
| PTP4A1 | 7803 | 2.5±0.5 | 5.7 | 2.2±0.6 | 4.6 | ||||
|
| 3576 | 2.5±0.0 | 5.7 | 1.5±0.6 | 2.8 | ○ | ○ | ||
|
| 1026 | 2.4±0.6 | 5.3 | 1.8±0.2 | 3.5 | ○– | ○ | ○ | ○ |
|
| 5055 | 2.4±0.4 | 5.3 | 1.8±0.0 | 3.5 | ○ | |||
| RSL1D1 | 26156 | 2.3±0.2 | 4.9 | 2.3±0.2 | 4.9 | ||||
| MARCKSL1 | 65108 | 2.0±0.3 | 4.0 | 1.7±0.0 | 3.2 | ||||
Symbols and Gene ID are from http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene.
GOstat analysis was performed using software hosted at http://gostat.wehi.edu.au/. Statistically overrepresented GO annotations were apoptosis (GO:0006915, P = 1.5×10−6), response to stress (GO:0006974, P = 1.5×10−6) and negative regulation of cell proliferation (GO:0008285, P = 1.3×10−7), and related annotations.
Known p53-induced transcripts were identified from a recent comprehensive survey [20].
Fold increase in expression following UV exposure is expressed as the mean (log2) ± standard error determined by microarray from 2 independent experiments. Samples were transfected with either control (NT) or CIRBP siRNAs.
Fold increase in expression (see c) in linear form (2log2mean).
Expression of transcripts in bold were independently confirmed by q-RT-PCR.
The symbol ‘○’ is used to designate that the indicated transcript was annotated with the indicated GO term. Within the GO term apoptosis (GO:0006915), the ‘–‘ superscript denotes negative regulators of apoptosis (GO: 0043066).
Potential CIRBP-dependent gene expression determined by microarray analysis.
| Symbol | Expression | GO Annotation | ||||
| NT | CIRBP | Stress | Inflammation | |||
| IL1B | 3.4±0.9 | 10.6 | 1.0±0.2 | 2.0 | ○ | ○ |
| TNFAIP6 | 2.6±0.5 | 6.1 | 1.4±0.1 | 2.6 | ○ | ○ |
| IL8 | 2.5±0.0 | 5.7 | 1.5±0.6 | 2.8 | ○ | ○ |
| HMOX1 | 2.8±0.9 | 7.0 | 1.8±1.1 | 3.5 | ○ | |
| HSPB6 | 5.1±1.6 | 34.3 | 2.7±2.5 | 6.5 | ○ | |
Gene symbol and ID were obtained from http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene.
GOstat analysis was performed using software hosted at http://gostat.wehi.edu.au/. Statistically overrepresented GO annotations were inflammatory response (GO:0006954, P = 1.7 10−4), response to stress (GO:0006950, P = 2.0×10−5), and related annotations.
Fold increase in expression following UV exposure is expressed as the mean (log2) ± standard error determined by microarray from 2 independent experiments. Samples were transfected with either control (NT) or CIRBP siRNAs.
Fold increase in expression (see c) in linear form (2log2mean).
The symbol ‘○’ is used to designate that the indicated transcript was annotated with the indicated GO term.
Figure 2The CIRBP-dependent UVC-induced accumulation of IL1B, IL8 and TNFAIP6 mRNAs.
(A) Fibroblasts were transfected with either control (NT), CIRBP or IL1B siRNAs, 72 hours later cells were exposed to either 0 or 20 J/m2 of UVC light and total RNA was collected at the indicated time following UVC exposure for qRT-PCR analysis of the indicated mRNAs. (B) Fibroblasts were similarly transfected with siRNAs 72 hours prior to UV exposure Cells were collected by scraping and IL-1β protein was measured by ELISA at 16 hours following UVC exposure. (C) Cells were transfected with the indicated expression vector and 24 hours later cells were collected and analyzed as described in (B). Each value in A, B and C represents the mean (± SEM) determined from a minimum of 3 independent experiments. An * indicates that the value is significantly different than similarly treated control samples (P≤0.05, t test) while a # indicates that the value is significantly different from 1.0 (P≤0.05, single sample t-test).
Figure 3RNA interference against CIRBP prevents the induction of IL1B mRNA in response to UVB and cisplatin.
Fibroblasts were transfected with non-targeting control (NT) or CIRBP siRNAs 72 hours prior to treatment with 150 J/m2 of UVB light (A), 20 µM cisplatin (B) or moderate hypothermia (32°C) for 24 hours (C). (A–C) At the indicated time, total RNA was collected for qRT-PCR analysis of the indicated transcript. Each value in A–C represents the mean (±SEM) determined from a minimum of 3 independent experiments. The * indicates that the mean is significantly different from 1.0 (P≤0.05, single sample t-test).
Figure 4Phosphorylation of IκB is impaired in CIRBP siRNA transfected cells exposure to either UVC or LPS.
(A) Fibroblasts were transfected with non-targeting control (NT) or CIRBP siRNA 72 hours prior to treatment with 0.5 µg/mL LPS. Total RNA was collected at the indicated time for qRT-PCR analysis. (B) Fibroblasts were similarly treated but IL-1β levels were assessed by ELISA 6 hours following addition of LPS. (C and D) Fibroblasts were exposed to BMS-345541 (BMS) or vehicle control at the time of cell treatment (0 or 20 J/m2 UVC or 0.5 µg/mL LPS). Total RNA was collected for qRT-PCR of IL1B expression at the indicated time following UVC (C) or 6 hours following LPS treatment (D). Each value in A–D represents the mean (±SEM) determined from a minimum of 3 independent experiments. An * denotes that the indicated means are significantly different from similarly treated control samples by t-test (P≤0.05) while a # indicates that the mean is not equal to 1.0 (P≤0.05, single sample t-test). (E) Fibroblasts were transfected with siRNA, as described in A, and then whole cell lysates were collected at the indicated time following LPS treatment for immunoblot analysis of phospho- IκB, total-IκB, CIRBP and β-actin, as indicated. Similar results were obtained in 4 independent experiments.
Figure 5Electrophoretic mobility shift assay.
Fibroblasts were transfected with the indicated siRNA 72 hours prior to a 45 min LPS treatment after which nuclear extracts were collected for electrophoretic mobility shift assays. The position of p50/p50 and p50/p65 DNA binding complexes and anti-p50 supershift complexes are indicated (upper blot). SP1 DNA binding activity was included as a loading control (lower blot). Similar results were obtained in two independent experiments.